From: Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers
Complications | Group A n (%) | Group B n (%) | Group C n (%) | P value |
---|---|---|---|---|
Cardiac | 7 (10.1) | 1 (1.7) | 1 (1.9) | NS (0.272) |
Pulmonary | 1(1.4) | 1 (1.7) | 4 (7.5) | NS (0.140) |
Urinary | 12 (17.4) | 2 (3.4) | 3 (5.7) | NS (0.380) |
Surgical | Â | Â | Â | Â |
   Intraoperative | 2 (2.8) | 0 (0) | 1 (1.9) |  |
   Postoperative | 1 (1.4) | 2 (3.4) | 0 (0) | NS (0.314) |
Wound | 6 (8.7) | 8 (13.8) | 8 (15.1) | NS (0.209) |
Leak | 0 (0) | 2 (22) | 2 (10) | NS (0.438) |
Re-operation | 7 (10.1) | 3 (5.2) | 2 (3.8) | NS (0.604) |
30-day mortality | 1 (1.4) | 0 (0) | 0 (0) | NS |
Overall perioperative complication | 30 (43.4) | 17 (29.3) | 21 (39.6) | NS |
 |  |  |  | NS |